Cart
sales@molnova.com
debutylbupivacaine
CAS No. 15883-20-2
debutylbupivacaine ( Desbutylbupivacaine; Debutylbupivacaine; Demethylmepivacaine )
Catalog No. M12267 CAS No. 15883-20-2
It is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 45 | In Stock |
|
| 25MG | 57 | In Stock |
|
| 50MG | 98 | In Stock |
|
| 100MG | 174 | In Stock |
|
| 200MG | 312 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namedebutylbupivacaine
-
NoteResearch use only, not for human use.
-
Brief DescriptionIt is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
-
DescriptionIt is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
-
SynonymsDesbutylbupivacaine; Debutylbupivacaine; Demethylmepivacaine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15883-20-2
-
Formula Weight232.32
-
Molecular FormulaC14H20N2O
-
Purity>98%(HPLC)
-
SolubilityLimited solubility
-
SMILESO=C(C1NCCCC1)NC2=C(C)C=CC=C2C
-
Chemical Name2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pihlajamki K, et al. Br J Anaesth. 1990 May;64(5):556-62.
molnova catalog
related products
-
(-)-Syringaresinol 4...
(-)-Syringaresinol inhibits the proliferation of human promyelocytic HL-6 cells through G(1) arrest and induction of apoptosis, may be a potential chemotherapeutic agent for the treatment of cancer.
-
Cefoperazone
Cefoperazone binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall.
-
Ganoderenic acid E
Ganoderenic acid E is a natural product.
